BIOLOGICAL · Unmapped registry intervention
Ipilimumab
Find medicine records ·
Find other trials using this name
Clinical trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
NCT02785952
Study summary
ClinicalTrials.govLung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Laboratory Biomarker Analysis
Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
Nivolumab
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Quality-of-Life Assessment
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Questionnaire Administration
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Interventions
IpilimumabBIOLOGICAL
NivolumabBIOLOGICAL
Sponsors & collaborators
SWOG Cancer Research Networklead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Las VegasNevada, United States25HonoluluHawaii, United States12DenverColorado, United States11SeattleWashington, United States10PittsburghPennsylvania, United States10CincinnatiOhio, United States10OmahaNebraska, United States10AnchorageAlaska, United States9HoustonTexas, United States8BaltimoreMaryland, United States8ColumbusOhio, United States8LouisvilleKentucky, United States8
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02785952 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.